Sun Pharmaceutical Industries’ subsidiary - Caraco has received an approval for its manufacturing facility by the U.S Food and Drug Administration (USFDA). The regulator on June 2011 had re-inspected the company’s manufacturing facility located at Cranbury, New Jersey, for which the site has received an acceptable regulatory status. Therefore, the issue noted in the August 25, 2010, warning letter are considered to be resolved. Caraco, wholly owned by Sun Pharma, continues to work with consultants to resolve the issue raised by the USFDA at its Detroit plant.
Recently, the company’s subsidiary had been granted approval from USFDA for its Abbreviated New Drug Application (ANDA) for generic version of Plavix, clopidogrel tablets USP.
Sun Pharmaceutical Industries manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1872.40 |
| Dr. Reddys Lab | 1279.70 |
| Cipla | 1304.70 |
| Zydus Lifesciences | 956.65 |
| Lupin | 2245.65 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: